LPL Financial’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.46M | Buy |
194,579
+9,121
| +5% | +$444K | ﹤0.01% | 1769 |
|
|
2025
Q1 | $6.31M | Buy |
185,458
+35,732
| +24% | +$1.22M | ﹤0.01% | 1955 |
|
|
2024
Q4 | $5.89M | Buy |
149,726
+42,232
| +39% | +$1.66M | ﹤0.01% | 1932 |
|
|
2024
Q3 | $5.05M | Sell |
107,494
-8,597
| -7% | -$404K | ﹤0.01% | 1975 |
|
|
2024
Q2 | $6.27M | Buy |
116,091
+10,171
| +10% | +$549K | ﹤0.01% | 1685 |
|
|
2024
Q1 | $7.22M | Buy |
105,920
+13,459
| +15% | +$917K | ﹤0.01% | 1533 |
|
|
2023
Q4 | $5.79M | Buy |
92,461
+1,662
| +2% | +$104K | ﹤0.01% | 1588 |
|
|
2023
Q3 | $4.12M | Buy |
90,799
+46
| +0.1% | +$2.09K | ﹤0.01% | 1703 |
|
|
2023
Q2 | $5.09M | Buy |
90,753
+9,040
| +11% | +$508K | ﹤0.01% | 1547 |
|
|
2023
Q1 | $3.7M | Buy |
81,713
+3,828
| +5% | +$173K | ﹤0.01% | 1692 |
|
|
2022
Q4 | $3.17M | Sell |
77,885
-274
| -0.4% | -$11.1K | ﹤0.01% | 1735 |
|
|
2022
Q3 | $5.11M | Buy |
78,159
+6,140
| +9% | +$401K | ﹤0.01% | 1363 |
|
|
2022
Q2 | $4.38M | Buy |
72,019
+6,647
| +10% | +$404K | ﹤0.01% | 1495 |
|
|
2022
Q1 | $4.1M | Buy |
65,372
+13,240
| +25% | +$831K | ﹤0.01% | 1560 |
|
|
2021
Q4 | $3.95M | Sell |
52,132
-3,286
| -6% | -$249K | ﹤0.01% | 1610 |
|
|
2021
Q3 | $6.2M | Buy |
55,418
+5,788
| +12% | +$648K | 0.01% | 1247 |
|
|
2021
Q2 | $8.04M | Buy |
49,630
+3,324
| +7% | +$538K | 0.01% | 1038 |
|
|
2021
Q1 | $5.64M | Sell |
46,306
-10,226
| -18% | -$1.25M | 0.01% | 1146 |
|
|
2020
Q4 | $8.66M | Buy |
56,532
+19,840
| +54% | +$3.04M | 0.01% | 816 |
|
|
2020
Q3 | $3.07M | Sell |
36,692
-20,636
| -36% | -$1.73M | ﹤0.01% | 1208 |
|
|
2020
Q2 | $4.21M | Buy |
57,328
+35,131
| +158% | +$2.58M | 0.01% | 963 |
|
|
2020
Q1 | $941K | Buy |
22,197
+3,363
| +18% | +$143K | ﹤0.01% | 1652 |
|
|
2019
Q4 | $1.15M | Buy |
18,834
+5,729
| +44% | +$349K | ﹤0.01% | 1725 |
|
|
2019
Q3 | $537K | Sell |
13,105
-20,193
| -61% | -$827K | ﹤0.01% | 2206 |
|
|
2019
Q2 | $1.57M | Buy |
33,298
+25,047
| +304% | +$1.18M | ﹤0.01% | 1388 |
|
|
2019
Q1 | $295K | Sell |
8,251
-1,558
| -16% | -$55.7K | ﹤0.01% | 2634 |
|
|
2018
Q4 | $280K | Buy |
9,809
+1,924
| +24% | +$54.9K | ﹤0.01% | 2504 |
|
|
2018
Q3 | $350K | Buy |
7,885
+1,138
| +17% | +$50.5K | ﹤0.01% | 2529 |
|
|
2018
Q2 | $396K | Buy |
6,747
+1,137
| +20% | +$66.7K | ﹤0.01% | 2384 |
|
|
2018
Q1 | $256K | Buy |
+5,610
| New | +$256K | ﹤0.01% | 2747 |
|